An essential receptor for adeno-associated virus infection
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors are currently the leading candidates for virus-based gene therapies because of their broad tissue tropism, non-pathogenic nature and low immunogenicity. They have been successfully used in clinical trials to treat hereditary diseases such as haemophilia B (ref. 2), and have been approved for treatment of lipoprotein lipase deficiency in Europe. Considerable efforts have been made to engineer AAV variants with novel and biomedically valuable cell tropisms to allow efficacious systemic administration, yet basic aspects of AAV cellular entry are still poorly understood. In particular, the protein receptor(s) required for AAV entry after cell attachment remains unknown. Here we use an unbiased genetic screen to identify proteins essential for AAV serotype 2 (AAV2) infection in a haploid human cell line. The most significantly enriched gene of the screen encodes a previously uncharacterized type I transmembrane protein, KIAA0319L (denoted hereafter as AAV receptor (AAVR)). We characterize AAVR as a protein capable of rapid endocytosis from the plasma membrane and trafficking to the trans-Golgi network. We show that AAVR directly binds to AAV2 particles, and that anti-AAVR antibodies efficiently block AAV2 infection. Moreover, genetic ablation of AAVR renders a wide range of mammalian cell types highly resistant to AAV2 infection. Notably, AAVR serves as a critical host factor for all tested AAV serotypes. The importance of AAVR for in vivo gene delivery is further highlighted by the robust resistance of Aavr(-/-) (also known as Au040320(-/-) and Kiaa0319l(-/-)) mice to AAV infection. Collectively, our data indicate that AAVR is a universal receptor involved in AAV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The peptide insertion at position R588 in R100 sterically prohibits the close proximity between R585 and R588 required for heparan sulfate binding ( Fig. 5 B), suggesting a plausible mechanism for enhanced transit through the heparan sulfate-rich ILM barrier.”
From Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies (2024) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Self-citationMannose 6-phosphate receptors: new twists in the tale
Ghosh, P., Dahms, N. M., & Kornfeld, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1050 · Cited by 1,086
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Campeau, E., Ruhl, V. E., Rodier, F., Smith, C. L., Rahmberg, B. L., Fuss, J. O., Campisi, J., Yaswen, P., Cooper, P. K., & Kaufman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006529 · Cited by 964
Cited by
Items 301–400 of 524
Selection of a novel AAV2/TNFAIP3 vector for local suppression of islet xenograft inflammation
Zammit, N. W., Seeberger, K. L., Zamerli, J., Walters, S. N., Lisowski, L., Korbutt, G. S., & Grey, S. T. (2020) · Xenotransplantation · doi:10.1111/xen.12669 · Cited by 10
Structure of parvovirus B19 decorated with Fab molecules from a human antibody
Rossmann, M. G., Sun, Y., Klose, T., & Liu, Y. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6nn3/pdb · Cited by 8
Preclinical Models of Solid Cancers for Testing Cancer Immunotherapies
Expósito, F., Connolly, K. A., Tang, T., Chiorazzi, M., Hunt, B. G., Cardenas, J. J., Nguyen, D. X., Joshi, N. S., & Politi, K. A. (2025) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-024810 · Cited by 13
Song, Q., Wu, J., Zhang, Q., Wu, S. V., Luo, X., Xu, M., Xu, Y., Wang, G., Yu, H., Chen, H., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101522 · Cited by 8
“33,34 In this study, we identified essential host factors that contribute to the superior transduction efficiency of BRC05 and BRC06 through a genome-wide knockout screen on N2a-Cas9 cells.”
Sharma, S., Joshi, V., & Kumar, V. (2025) · Clinical and Translational Neuroscience · doi:10.3390/ctn9030032 · Cited by 8
“In addition, cellular uptake is dependent on the presence of specific receptors, and suboptimal internalization at the target site further hampers therapeutic efficacy [47].”
A single amino acid variant in the variable region I of AAV capsid confers liver detargeting
Xing, R., Xu, M., Reil, D., Destefano, A., Cui, M., Liu, N., Liang, J., Xu, G., Luo, L., Xu, M., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013533 · Cited by 8
Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids
Brittain, T. J., Jang, S., Coughlin, G. M., Hoang, J. D., Barcelona, B. H., Giriat, I., Ristic, F., Appling, N., Chossis, C. P., Shay, T. F., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.030 · Cited by 11
“Another crucial factor is the AAV receptor (AAVR) 29–31 , AAVR is expressed on the cell surface across various organs and tissues 32–36 .”
InfluentialGünther, D. M., Kovacs, R., Wildner, F., Salivara, A., Thalheimer, F. B., Fries, P., Geiger, J. R. P., & Buchholz, C. J. (2023) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2023.109981 · Cited by 12
“For cell entry, most AAV serotypes use modifications on surface proteins for cell attachment followed by contacting the AAV receptor (AAVR) for membrane penetration and intracellular transport (Pillay et al., 2016).”
Antiviral Defence Mechanisms during Early Mammalian Development
Mueller, F., Witteveldt, J., & Macías, S. (2024) · Viruses · doi:10.3390/v16020173 · Cited by 8
Wang, H., Li, R., Sadekar, S., Kamath, A. V., & Shen, B. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101326 · Cited by 8
“45,46 In AAV2-infected cells, vector cellular uptake and accumulation of the AAV vectors were captured by qPCR and 111 In radioactivity, where a continuous increase in signal was observed.”
Pipatpadungsin, N., Chao, K., & Rouse, S. L. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c03087 · Cited by 10
BCL2 is a major regulator of haploidy maintenance in murine embryonic stem cells
Sun, S., Zhao, Q., Zhao, Y., Geng, M., Wang, Q., Gao, Q., Zhang, X., Zhang, W., & Shuai, L. (2023) · Cell Proliferation · doi:10.1111/cpr.13498 · Cited by 9
“31 Unlike haploid tumour cells, haESCs do not have genomic variations and have the potential to differentiate into any desired lineage 25 ; thus, haESCs are promising in many more areas when used in genetic screening.”
BackgroundHunter, J. E., Molony, C. M., Bagel, J. H., O’Donnell, P. A., Kaler, S. G., & Wolfe, J. H. N. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.07.007 · Cited by 8
Peek, J. L., Rosales, A., Qi, J., Feleke, L., Menshikh, A., Welch, R., Woodard, L. E., Asokan, A., & Wilson, M. H. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201736 · Cited by 1
Vector Integration Sites Identification for Gene-Trap Screening in Mammalian Haploid Cells
Yu, J., & Ciaudo, C. (2017) · Scientific Reports · doi:10.1038/srep44736 · Cited by 6
Dengue Fever in a One Health Perspective - Latest Research and Recent Advances
Sperança, M. A. (2023) · Infectious diseases · doi:10.5772/intechopen.104140 · Cited by 7
Prospective approaches to gene therapy computational modeling – spotlight on viral gene therapy
Choules, M. P., Bonate, P. L., Heo, N., & Weddell, J. C. (2023) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09889-1 · Cited by 9
Handyside, B., Zhang, L., Yates, B., Xie, L. Y., Ismail, A. M., Murphy, R., Baridon, B., Su, C., Bouwman, T., Mangini, L., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.065 · Cited by 8
Genome-wide CRISPR screenings identified SMCHD1 as a host-restricting factor for AAV transduction
Wang, C., Liu, Y., Xiong, J., Xie, K., Wang, T., Hu, Y., Fu, H., Zhang, B., Huang, X., Bao, H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012344 · Cited by 7
Hoffman, J. A., Denton, N., Sims, J. J., Meggersee, R., Zhang, Z., Olagbegi, K., & Wilson, J. M. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.050 · Cited by 7
“46,47 Speci fi - cally, W503 is involved in the binding of both galactose and AAVR, 43,47 a residue that was altered via the W503H substi-tution in all XRH vectors.”
Adeno-Associated Virus 5 Protein Particles Produced by E. coli Cell-Free Protein Synthesis
Deuker, D., Asilonu, E., Bracewell, D. G., & Frank, S. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00403 · Cited by 6
AAVR Expression is Essential for AAV Vector Transduction in Sensory Hair Cells
Wu, F., Chen, G., Hu, R., Liu, P., Lou, J., Zhao, W., He, Z., Sha, S., & Zheng, Y. (2025) · Advanced Science · doi:10.1002/advs.202408873 · Cited by 6
Structural Capsidomics of Single-Stranded DNA Viruses
Mietzsch, M., Bennett, A. D., & McKENNA, R. V. (2025) · Viruses · doi:10.3390/v17030333 · Cited by 8
“Several glycan and proteinaceous receptors have been identified for different viruses [79–84].”
Recent Advances in Canine Medicine
Fonseca‐Alves, C. E. (2022) · Veterinary medicine and science · doi:10.5772/intechopen.100825 · Cited by 6
Characterization and biodistribution of under-employed gene therapy vector AAV7
Yost, S. A., Firlar, E., Glenn, J. D., Carroll, H. B., Foltz, S. J., Giles, A. R., Egley, J. M., Firnberg, E., Cho, S., Nguyen, T. T. H., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01163-23 · Cited by 8
“AAV7 was able to transduce HEK293T cells at similar levels compared to AAV8 and AAV9 based on total TdTomato fluorescence; however, in HEK293T-AAVR cells, AAV9 and AAV8 transduction is significantly greater than AAV7 (Fig.”
ResultInfluentialMaking Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for Infection
Riblett, A. M., & Doms, R. W. (2016) · Viruses · doi:10.3390/v8050130 · Cited by 6
Using Human iPSC-Derived Neurons to Uncover Activity-Dependent Non-Coding RNAs
Bitar, M., Kuiper, S., O’Brien, E., & Barry, G. (2017) · Genes · doi:10.3390/genes8120401 · Cited by 6
“While KIAA0319 is involved in neural migration and outgrowth and is associated with dyslexia susceptibility [66], its structural homologue KIAA0319L is an adeno-associated virus receptor that mediates viral infection [67].”
BackgroundReverse transduction can improve efficiency of AAV vectors in transduction‐resistant cells
Lee, E. J., Robinson, T. M., Tabor, J. J., Mikos, A. G., & Suh, J. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26830 · Cited by 8
“Moreover, AAVR is a recently identified receptor shown to be necessary for infection by multiple variants, including AAV2 and AAV9 (Pillay et al., 2016; Pillay et al., 2017).”
Gene Therapy in Pediatric Liver Disease
Muro, A. F., D’Antiga, L., & Mingozzi, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-96400-3_44 · Cited by 7
Bieńkowska, A., Kuźmicka, W., Ciepiela, O., Ochocki, J., & Małecki, M. (2020) · BioMed Research International · doi:10.1155/2020/9107140 · Cited by 6
Casey, G., Askew, C., Brimble, M. A., Samulski, R. J., Davidoff, A. M., Li, C., & Walters, B. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242599 · Cited by 7
López-Gordo, E., Orlowski, A., Wang, A., Weinberg, A. D., Sahoo, S., & Weber, T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.732095 · Cited by 6
“For instance, it will be interesting to analyze the influence of other host entry factors [e.g., AAVR or GRP108] (16, 44–46) on transduction in the two mice strains.”
BackgroundInfluentialRostami, M. R., Leopold, P. L., Vasquez, J. M., Rougvie, M. D. M., Al-Shakaki, A., Hssain, A. A., Robay, A., Hackett, N. R., Mezey, J. G., & Crystal, R. G. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101136 · Cited by 5
“…the knockdown of B3GAT3 reduced cell fi tness as shown in a reduced rate of growth of cells harboring this mutation. g Identi fi ed in Pillay et al. 30 and Meisen et al., 59 but failed validation in Meisen et al. 59 h Both EXT1 and EXT2 were identi fi ed in screens by Pillay et al. 30 and Meisen et…”
BackgroundInfluentialChronobiology of neurotropic viruses: rhythmic viral entry and arrhythmic host clocks
Zeng, S., Zhang, Q., Yang, X., Lv, L., Zhang, Y., Zhang, Z., Wang, Q., Luo, M., Dorf, M. E., Li, S., et al. (2026) · Cell Discovery · doi:10.1038/s41421-026-00867-8 · Cited by 5
“Recognition and interaction between viruses and receptors are critical initial steps in the viral life cycle 12 – 16 .”
Fu, J., Zheng, H., Ou, Y., Yang, G., Chen, Z., & Yuan, G. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.008 · Cited by 5
“28 EGFR is a co-receptor that is necessary for AAV6 vector internalization.”
Zengel, J. R., Esterman, E. S., Ponnuswami, A., Wall, N. R., & Carette, J. E. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101416 · Cited by 5
“9 A single-guide RNA (sgRNA) (5 0 -CGTCCTCAGAGCTACTGTCC- 3 0 ) was selected to target the SETDB1 gene on chromosome 1 at position 150930029 on the negative strand.”
Self-citationKehr, D., Salatzki, J., Seger, B., Varadi, K., Birkenstock, J., Schlegel, P., Gao, E., Koch, W. J., Riffel, J., André, F., et al. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.012479 · Cited by 8
Organoid transduction using recombinant adeno‐associated viral vectors: Challenges and opportunities
Belova, L., Лавров, А. В., & Smirnikhina, S. (2022) · BioEssays · doi:10.1002/bies.202200055 · Cited by 6
“The biodiversity of AAV receptors and co-receptors on the cell surface, such as proteoglycans,[48] sialic acids,[49] universal AAV receptor (AAVR),[50] and so on facilitates the selective penetration of virions into cells of various types (Table 1), leading to a high tropism of AAV.”
BackgroundCulture of Human Retinal Explants for Ex Vivo Assessment of AAV Gene Delivery
Wu, W.-H., Tso, A., Breazzano, M. P., Jenny, L. A., Levi, S. R., Tsang, S. H., & Quinn, P. M. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_28 · Cited by 6
Piletska, E. V., Veron, P., Bertin, B., Mingozzi, F., Jones, D. J. L., Norman, R. L., Earley, J., Karim, K., García‐Cruz, Á., & Piletsky, S. A. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102691 · Cited by 5
Fehrman, R. L., Chern, K. J., Stoltz, K. P., & Lipinski, D. M. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110223 · Cited by 5
O'Driscoll, E., Arora, S., Lang, J. F., Davidson, B. L., & Shalem, O. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101408 · Cited by 7
Haploid Screening for the Identification of Host Factors in Virus Infection
Fessler, E., & Jae, L. T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8678-1_6 · Cited by 7
Self-citationTargeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy
Cagin, U. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_15 · Cited by 5
Zoabi, S., Andreyanov, M., Heinrich, R., Ron, S., Carmi, I., Gutfreund, Y., & Berlin, S. (2023) · Communications Biology · doi:10.1038/s42003-023-04712-6 · Cited by 6
Rajapaksha, I. G., Angus, P., & Herath, C. B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80317 · Cited by 7
“Recently, Pillay and colleagues [25] used a library of mutagenized haploid HAP1 cells to create knockouts of nearly all nonessential genes in the human genome.”
BackgroundReprogramming Adeno-Associated Virus Tropism Via Displayed Peptides Tiling Receptor-LigandsPreprint
Portell, A. J., Ford, K. M., Suhardjo, A., Rainaldi, J., Bublik, M. N., Sanghvi, M., Kumar, A., Wing, M. K., Palmer, N. D., Le, D. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.26.509383 · Cited by 5
Hippocampal CA2 neurons disproportionately express AAV-delivered genetic cargoPreprint
Alexander, G. M., He, B., Leikvoll, A., Jones, S., Wine, R. N., Kara, P., Martin, N. P., & Dudek, S. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.27.625768 · Cited by 6
The glycolytic enzyme PFKFB3 alleviates DNA damage and chondrocyte senescence in osteoarthritis
Liu, B., Wang, C., Weng, Z., Yang, Y., Shi, Y., & Zhang, C. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02903-0 · Cited by 4
“Pristimerin (#HY-N1937) and IT901 (#HY-124179) were purchased from MedChemExpress (Monmouth Junction, NJ, USA).”
Identification of CD164 as an essential entry receptor for divergent adeno-associated viruses
Zhang, X., Richart, D., McFarlin, S., Cheng, F., Park, S. Y., Zhang-Chen, A., McFarlane, R., Xiao, C., Yan, Z., & Jianming, Q. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525865123 · Cited by 9
“F and H (30, 34), and the G protein–coupled receptor GPR108 is essential for intracellular trafficking of most AAV serotypes, except Clade H AAV5 (31).”
Chen, S., He, B., Singh, S., & Martin, N. P. (2023) · Neuromethods · doi:10.1007/978-1-0716-2918-5_6 · Cited by 6
Yoo, J. S., Park, I., Jwa, S., Lee, S. H., Hong, S., & Park, T. H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c01846 · Cited by 6
Cui, M., Zhao, Q., Wang, J., Si, Y., Cheng, S., & Ding, W. (2021) · Journal of Virology · doi:10.1128/jvi.01103-21 · Cited by 4
“portion which are linked to a single-pass membrane-spanning helix (10).”
BackgroundInfluentialInterplay between Furin and Sialoglycans in Modulating Adeno-Associated Viral Cell Entry
Smith, T. J., Fusco, R. M., Elmore, Z. C., & Asokan, A. (2023) · Journal of Virology · doi:10.1128/jvi.00093-23 · Cited by 4
“Two essential host factors, AAVR and GPR108, have been reported for AAV transduction (11, 12).”
BackgroundYadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232264527231013072728 · Cited by 4
Go, N., Ahn, C.-H., & Lee, J. Y. (2024) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-024-00003-x · Cited by 4
“While these studies highlight the importance of AAVR and GPR108 as crucial AAV entry factors, genetic complement studies were performed in either AAVR or GPR108 knockout background, disregarding potential differences in basal expression levels of AAVR or GPR108 in different cell lines [3, 4].”
InfluentialLaw, W., Warren, R. L., & McCallion, A. S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.01.009 · Cited by 4
Pushchina, E. V., Bykova, M. E., Shamshurina, E. V., & Alekseevich, V. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094947 · Cited by 4
“Some biochemical and genetic data have been obtained that show the cell surface heparan sulfate proteoglycan (HSPG) to serve as the primary receptor for AAV attachment [25].”
BackgroundInfluentialSphingolipid Biosynthesis Inhibition As A Host Strategy Against Diverse PathogensPreprint
Kumar, S., Li, J., Park, J., Hart, S. K., Song, N., Burrow, D. T., Bean, N. L., Jacobs, N. C., Coler-Reilly, A. L. G., Onyshchenko, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.10.035683 · Cited by 5
“In the last decade there have been numerous genome-scale screens to identify host factors responsible for the toxic effects of pathogens including Ebola (6), adeno-associated AAV2 (7), HIV (8), Rotavirus (9), Influenza A (10), Zika virus (11), Picornavirus (12), Exotoxin A (13), Cholera toxin (14), Type III secretion…”
BackgroundSelf-citationGrimm, D., & Nonnenmacher, M. E. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.04.007 · Cited by 3
Song, S., Zhang, X., Huang, Z., Pei, Z., Zeng, L., Cai, F., Wang, T., Li, M., Liu, C., Song, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202508673 · Cited by 4
Fong, S., Swystun, L. L., Batty, P. A., & Lillicrap, D. (2026) · Therapeutic Advances in Hematology · doi:10.1177/20406207251406537 · Cited by 4
“50,55 Cellular intake occurs via different pathways, including clathrin-mediated endocytosis, clath-rin-independent carriers, and GPI-enriched endocytic compartment endocytosis and micropi-nocytosis.”
Pak, A., Wear, D., Tahmasian, N., Min, J. Y., Premraj, D. K., Gibbs, R., Spencer, K. A., Fang, S., Zerbes, T., Krishnan, M. R., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1768545 · Cited by 3
“The initial contact with cells may rely on surface glycans (Bell et al., 2011; Shen et al., 2011) and the coreceptor KIAA0319L, also known as the AAV receptor (AAVR), which has broad affinity for a wide range of natural AAV serotypes (Pillay et al., 2016; Summerford et al., 2016).”
How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress
Vernone, A., Bergandi, L., Pernice, S., Pescarmona, G., & Silvagno, F. (2023) · Antioxidants · doi:10.3390/antiox12020483 · Cited by 3
Ju, X., Dong, L., & Ding, Q. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1304-6_10 · Cited by 3
Globoside Is an Essential Intracellular Factor Required for Parvovirus B19 Endosomal Escape
Bieri, J., Suter, C., Caliaro, O., Bartetzko, S., Bircher, C., & Ros, C. (2024) · Cells · doi:10.3390/cells13151254 · Cited by 4
Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier
Yao, Y., & Bei, F. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_4 · Cited by 4
Hull, J. A., Fusco, R. M., Tan, J., Ochoa, M. A., Hall, A., Wan, X., Loeb, E., & Asokan, A. (2025) · Journal of Virology · doi:10.1128/jvi.00799-25 · Cited by 3
“Surface structural features on the capsid formed by interdigitation of VP3 variable loop regions are responsible for cellular glycan and protein receptor binding interactions and are the most common target of serological immune recognition and neutralization (5, 8–13).”
Cabanes‐Creus, M., Liao, S. H. Y., Pardo-Piñón, M., Rojas, A. L., Kelich, J. M., Coyne, J., Knight, M., Nazareth, D., Roca-Pinilla, R., Senapati, S., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00337-26 · Cited by 5
“Based on accumulating evidence, it has been proposed that glycans may be more accurately described as cell-attachment factors rather than true entry receptors, as interactions with glycans alone are insufficient for productive transduction in the absence of AAVR (7, 9).”
InfluentialGene Therapy: Use of Viruses as Vectors
Nance, M. E., & Duan, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95711-8 · Cited by 3
Niu, G.-J., Zhu, X.-X., Lu, P.-Y., Yang, M., Yuan, W., & Wang, J. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737827 · Cited by 3
Calvo-López, T., Grueso, E., Sánchez-Martínez, C., & Almendral, J. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1063706 · Cited by 3
“Many parvoviruses used different types of sia as attachment factors and receptors (Walters et al., 2001; Di Pasquale et al., 2003; Schmidt et al., 2006; Weller et al., 2010; Allaume et al., 2012; Pillay et al., 2016; Pillay and Carette, 2017; Kulkarni et al., 2021), and a failed correspondence between capsid binding a…”
BackgroundMilagros, S., de Erenchun, P. R.-R., Guembe, M., Carte, B., Méndez, M., Uribarri, A., & Aldabe, R. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00430-7 · Cited by 4
“In 2016 AAV receptor (AAVR) was recognized as an essential receptor for the entry of various AAV sero-types [16].”
BackgroundIdentification of a novel neutralization epitope in rhesus AAVs
Dagotto, G., Fisher, J. L., Li, D., Li, Z., Jenni, S., Li, Z., Tartaglia, L. J., Abbink, P., & Barouch, D. H. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101350 · Cited by 3
“21,22 For these tests, we used RhAAV4282 expressing EGFP.”
Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections
Mnyandu, N., Jacobs, R., Arbuthnot, P. B., & Maepa, M. B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111360 · Cited by 3
“AAVR (adeno-associated virus receptor), a type I transmembrane protein, is known to stabilize the attachment of most AAV serotypes to the cell surface [20].”
Bieńkowska, A., & Małecki, M. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3183 · Cited by 3
Charish, J., Harada, H., Chen, X., Wälchli, T., Barr, C. L., & Monnier, P. P. (2023) · The International Journal of Developmental Biology · doi:10.1387/ijdb.230052pm · Cited by 3
Moroncini, G., Svegliati, S., Grieco, A., Cuccioloni, M., Mozzicafreddo, M., Paolini, C., Agarbati, S., Spadoni, T., Amoresano, A., Pinto, G., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42746 · Cited by 3
“23,42 Our data con fi rm previous fi ndings 23 that demonstrate that AAVR (the KIAA0319L transmembrane protein) is a receptor for multiple AAV serotypes, including AAV5.”
BackgroundPeroxisomal Membrane Protein PMP34 Is Involved in the Human Papillomavirus Infection Pathway
Ito, R., Kitamura, K., Inohara, H., Yusa, K., Kaneda, Y., & Nimura, K. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.870922 · Cited by 5
“The adeno-associated virus receptor (AAVR) was identified as a type I transmembrane protein, KIAA0319L, using haploid genetic screening and the role of AAVR was validated using CRISPR-Cas9 to generate AAVR-knockout cell lines (33).”
MethodGenomic loss of GPR108 disrupts AAV transduction in birdsPreprint
Nevue, A. A., Sairavi, A., Huang, S. J., Nakai, H., & Mello, C. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.16.589954 · Cited by 3
Engineering a highly durable adeno-associated virus receptor for analytical applications
Yoshida, K., Tsunekawa, Y., Kurihara, K., Watanabe, K., Makino-Manabe, Y., Wada, M., Tanaka, T., Ide, T., & Okada, T. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101157 · Cited by 3
Adeno-associated viruses in gene therapy for spinal muscular atrophies: trend or triumph?
Slobodkina, E. A., Akopyan, Z. A., & Макаревич, П. И. (2024) · Genes and Cells · doi:10.17816/gc516537 · Cited by 2
Ahuja, V., Jeyabalan, S., & Tzanakakis, E. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-05518-8 · Cited by 2
Mechanisms of AAV neutralization by human alpha-defensins
Porter, J. M., Hulce, K. R., Oswald, M. S., Busuttil, K., Emmanuel, S. N., Bennett, A. D., McKenna, R., & Smith, J. G. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013283 · Cited by 2
The Cold Case Files of rAAV Capsid Influence on Transduction: New Leads
Powell, S. (2025) · Viruses · doi:10.3390/v17111476 · Cited by 2
“Thus, given its importance to the gene therapy field, the rAAV capsid has been widely characterized in terms of cellular receptor binding that are serotype-specific (reviewed in [15]) or more broadly used primary receptors (AAVR [16] and AAVR2 [17]).”
Kieper, S. N., Spronck, E. A., Bourajjaj, M., Morais, R. D. V. S., van der Bent, M. L., Broekmans, Ş. A., van Rooijen, C., van Westen, R., Squeri, G., Brasser, G., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101642 · Cited by 2
“Additional experiments were conducted to determine whether AAV pan-receptor AAVR (KIAA0319L) interaction 37,38 was altered by the AAV5neo mutation.”
Mosaic AAV mediates efficient transduction across the central and peripheral nervous systems
Jiang, M., Yin, W., Mo, X., Wang, Z., Qiu, M. S., & Dai, Z. (2025) · Molecular Brain · doi:10.1186/s13041-025-01270-2 · Cited by 2
“Many CNS disorders are often associated with PNS-related issues [13], while diseases of the PNS can also impact the CNS [14], Most AAV vectors, due to their structural characteristics and receptor-binding properties, are limited to targeting either the CNS or PNS exclusively [15].”
Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy
Wang, Z., Wu, X., Fu, D.-Y., Li, X., Liu, D., Liu, S., Zhao, Q., & Wang, H. (2026) · Current Medical Science · doi:10.1007/s11596-026-00178-9 · Cited by 2
TBC1D23–AAVR interaction drives endosome-to-TGN trafficking required for rAAV transduction
Zhang, X., Habib, A., McFarlin, S., Richart, D., Park, S. Y., Cheng, F., Wang, J., Yan, Z., & Qiu, J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2605086123 · Cited by 2
Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives
Yang, M., Song, Y., Wang, Z., Chao, K., Li, L., Zhang, X., Duan, X., Yu, C., Xue, R., & Zhao, J. (2026) · MedComm · doi:10.1002/mco2.70791 · Cited by 5
Zajkowska, A., Czajka, M., Gulik, K., Gawrychowski, K., & Małecki, M. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/171745 · Cited by 2
Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
Benyamini, B., Esbin, M. N., Whitney, O. N., Walther, N., & Maurer, A. C. (2023) · Journal of Visualized Experiments · doi:10.3791/65572 · Cited by 2
Hyperthermia Enhances Adeno-Associated Virus Vector Transduction Efficiency in Melanoma Cells
Bieńkowska, A., Stelmaszczyk‐Emmel, A., Demkow, U. A., & Małecki, M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100537 · Cited by 2
“It has been shown that AAVR has a central role in binding AAV to cells and is essential for the internalization and efficient transduction of a wide range of cells [50].”
BackgroundResultCurrent status of hemophilia gene therapy
Kashiwakura, Y. (2024) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.35.60 · Cited by 2
Słyk, Ż., Stachowiak, N., & Małecki, M. (2024) · Pharmaceuticals · doi:10.3390/ph17091213 · Cited by 2
“Current knowledge of rAAV transmission was considered, including the importance of receptor signaling (AAVR and KIAA0319L) as postulated by Pillay et al. [48].”
BackgroundJacobsen, K. R., Mota, J., Salerno, M., Willis, A., Pitts, D., & Denner, J. (2024) · Viruses · doi:10.3390/v16101613 · Cited by 2
Kocher, F., & Hegemann, J. H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1519883 · Cited by 2
Глебовна, Г. А., Анатольевна, Е. М., Frolov, G. S., Khammadov, N. I., Hisamutdinov, A., Garipov, L. N., Mingaleev, D. N., & Ravilov, R. K. (2025) · Veterinary Medicine International · doi:10.1155/vmi/9191117 · Cited by 2
“AAVs belonging to the Dependoparvovirus genus of the Parvo-viridae family contain single-stranded DNA with inverted terminal repeat (ITR) and a protein capsid [17].”
Viral vectors for gene therapy
Tsai, A., Suzuki‐Hatano, S., & Pacak, C. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00019-8 · Cited by 2
Specific detection of duck adeno-associated virus using a TaqMan-based real-time PCR assay
Chen, S., Chen, Y., Zhang, M., Zhang, W., Fu, H., Huang, Y., Cheng, L., & Wan, C. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1483990 · Cited by 2
“At present, AAV can be divided into three groups, most of which have been detected in mammals (9).”
Metadata
- Authors
- Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., & Carette, J. E.
- Affiliations
- Stanford Medicine (US)
- Oregon Health & Science University (US)
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Chapman, M. S.
- Carette, J. E.
- ORCID
- Venue
- Nature
- Published
- 2016-01-27
- Volume
- 530
- Issue
- 7588
- Pages
- 108-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4962915
- OpenAlex
- W2266837556
- Cited by
- 532
- References
- 33
- Citations by year
- 2026: 58 · 2025: 51 · 2024: 63 · 2023: 60 · 2022: 36 · 2021: 47 · 2020: 57 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 28
- FWCI
- 43.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-09-28)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (5u19ai109662-05)
- National Institute of General Medical Sciences (R01GM066875)
- National Institute of Allergy and Infectious Diseases (DP2AI104557, U19-AI109662)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- adeno-associated virus, AAV receptor, AAV2, viral entry, host factors, endocytosis, AAV serotypes, gene therapy vectors, viral gene delivery
- MeSH terms
- Dependovirus, Animals, Antibodies, Cell Line, Endocytosis, Female, Humans, Male, Parvoviridae Infections, Receptors, Cell Surface, Receptors, Virus, Genetic Therapy, Gene Deletion, trans-Golgi Network, Mice, Virus Internalization, Viral Tropism, Host Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.